Would Wider Access to GLP-1s Throttle Addiction?
Cato Podcast · Cato Institute
January 31, 202514m 45s
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Drugs like Ozempic show potential to help those with addiction with little downside risk. How quickly can their availability be expanded? Nicholas Reville of CASPR makes his case.
Hosted on Acast. See acast.com/privacy for more information.